An evaluation of gabapentin and pregabalin usage in the treatment of neuropathic pain related to spinal cord injury

dc.contributor.authorKaya, Yasin Emre
dc.date.accessioned2021-06-23T18:24:54Z
dc.date.available2021-06-23T18:24:54Z
dc.date.issued2019
dc.departmentBAİBÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.description.abstractAim: In the present study, we aimed to systematically evaluate the effects of gabapentin and pregabalin, which are believed to be safe and well-tolerated and have analgesic, anticonvulsant, and anxiolytic effects, in the treatment of neuropathic pain after spinal cord injury despite their high side effect profiles. Material and Methods: A literature search of numerous electronic databases was performed. A combination of key words was used to retrieve studies published until November 1, 2018 correlated with the point of interest. The key words used were as follows: “spinal cord injury,” “neuropathic pain,” “gabapentin,” and “pregabalin.” Studies that met the inclusion criteria and were Level of I clinical trials were included in the study. The included studies were statistically evaluated. Results: In total, 125,515 publications were retrieved using the aforementioned key words. 19 studies on the use of gabapentin and pregabalin for the treatment of neuropathic pain associated with spinal cord injury were retrieved through. Conclusion: Studies suggested that available treatment modalities did not provide satisfactory outcomes for patients with neuropathic pain related to spinal cord injury. However, gabapentin and pregabalin were preferred as the first-line drugs in the treatment of neuropathic pain. The efficacy of gabapentin in the treatment of neuropathic pain after spinal cord injury has only been investigated in a few recent studies; data in these studies are not sufficiently clear and will need further clarification.en_US
dc.identifier.doi10.5455/annalsmedres.2018.12.281
dc.identifier.endpage528en_US
dc.identifier.issn2636-7688
dc.identifier.issn2636-7688
dc.identifier.issue3en_US
dc.identifier.startpage521en_US
dc.identifier.trdizinid315999en_US
dc.identifier.urihttps://doi.org/10.5455/annalsmedres.2018.12.281
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TXpFMU9UazVPUT09
dc.identifier.urihttps://hdl.handle.net/20.500.12491/1021
dc.identifier.volume26en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.institutionauthorKaya, Yasin Emre
dc.language.isoenen_US
dc.relation.ispartofAnnals of Medical Researchen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBiyolojien_US
dc.subjectDiş Hekimliğien_US
dc.subjectAlerjien_US
dc.subjectAnatomi ve Morfolojien_US
dc.subjectAndrolojien_US
dc.subjectAnestezien_US
dc.subjectOdyoloji ve Konuşma-Dil Patolojisien_US
dc.subjectBiyokimya ve Moleküler Biyolojien_US
dc.subjectBiyofiziken_US
dc.subjectBiyoteknoloji ve Uygulamalı Mikrobiyolojien_US
dc.subjectKalp ve Kalp Damar Sistemien_US
dc.subjectHücre Biyolojisien_US
dc.subjectKlinik Nörolojien_US
dc.subjectYoğun Bakım, Tıpen_US
dc.subjectDermatolojien_US
dc.subjectAcil Tıpen_US
dc.subjectEndokrinoloji ve Metabolizmaen_US
dc.subjectGastroenteroloji ve Hepatolojien_US
dc.subjectGeriatri ve Gerontolojien_US
dc.subjectSağlık Bilimleri ve Hizmetlerien_US
dc.subjectHematolojien_US
dc.subjectİmmünolojien_US
dc.subjectEnfeksiyon Hastalıklarıen_US
dc.subjectTamamlayıcı ve Entegre Tıpen_US
dc.subjectTıbbi Etiken_US
dc.subjectTıbbi İnformatiken_US
dc.subjectTıbbi Laboratuar Teknolojisien_US
dc.subjectGenel ve Dahili Tıpen_US
dc.subjectAdli Tıpen_US
dc.subjectTıbbi Araştırmalar Deneyselen_US
dc.subjectMikrobiyolojien_US
dc.subjectNörolojik Bilimleren_US
dc.subjectKadın Hastalıkları ve Doğumen_US
dc.subjectOnkolojien_US
dc.subjectGöz Hastalıklarıen_US
dc.subjectOrtopedien_US
dc.subjectKulak, Burun, Boğazen_US
dc.subjectPatolojien_US
dc.subjectPediatrien_US
dc.subjectPeriferik Damar Hastalıklarıen_US
dc.subjectFizyolojien_US
dc.subjectTemel Sağlık Hizmetlerien_US
dc.subjectPsikiyatrien_US
dc.subjectHalk ve Çevre Sağlığıen_US
dc.subjectRadyoloji, Nükleer Tıp, Tıbbi Görüntülemeen_US
dc.subjectRehabilitasyonen_US
dc.subjectSolunum Sistemien_US
dc.subjectRomatolojien_US
dc.subjectSpor Bilimlerien_US
dc.subjectCerrahien_US
dc.subjectTransplantasyonen_US
dc.subjectTropik Tıpen_US
dc.subjectÜroloji ve Nefrolojien_US
dc.subjectFarmakoloji ve Eczacılıken_US
dc.subjectToksikolojien_US
dc.titleAn evaluation of gabapentin and pregabalin usage in the treatment of neuropathic pain related to spinal cord injuryen_US
dc.typeOtheren_US

Dosyalar